Works by van Dam, Peter


Results: 102
    1
    2
    3
    4

    Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease.

    Published in:
    Molecular Oncology, 2015, v. 9, n. 6, p. 1218, doi. 10.1016/j.molonc.2015.02.006
    By:
    • Jansen, Maurice P.H.M.;
    • Sas, Leen;
    • Sieuwerts, Anieta M.;
    • Van Cauwenberghe, Caroline;
    • Ramirez-Ardila, Diana;
    • Look, Maxime;
    • Ruigrok-Ritstier, Kirsten;
    • Finetti, Pascal;
    • Bertucci, François;
    • Timmermans, Mieke M.;
    • van Deurzen, Carolien H.M.;
    • Martens, John W.M.;
    • Simon, Iris;
    • Roepman, Paul;
    • Linn, Sabine C.;
    • van Dam, Peter;
    • Kok, Marleen;
    • Lardon, Filip;
    • Vermeulen, Peter B.;
    • Foekens, John A.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Non-canonical Helitrons in Fusarium oxysporum.

    Published in:
    Mobile DNA, 2016, v. 7, p. 1, doi. 10.1186/s13100-016-0083-7
    By:
    • Chellapan, Biju Vadakkemukadiyil;
    • van Dam, Peter;
    • Rep, Martijn;
    • Cornelissen, Ben J. C.;
    • Fokkens, Like
    Publication type:
    Article
    14
    15
    16
    17

    The art of obtaining a high yield of cell-free DNA from urine.

    Published in:
    PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0231058
    By:
    • Augustus, Elien;
    • Van Casteren, Kaat;
    • Sorber, Laure;
    • van Dam, Peter;
    • Roeyen, Geert;
    • Peeters, Marc;
    • Vorsters, Alex;
    • Wouters, An;
    • Raskin, Jo;
    • Rolfo, Christian;
    • Zwaenepoel, Karen;
    • Pauwels, Patrick
    Publication type:
    Article
    18

    The Challenge of Calculating EUSOMA Quality Indicators with Administrative Data: A Pilot Study in Belgium.

    Published in:
    Breast Care, 2025, v. 20, n. 2, p. 88, doi. 10.1159/000543676
    By:
    • Leroy, Roos;
    • De Gendt, Cindy;
    • Bourgeois, Jolyce;
    • Verbeeck, Julie;
    • Savoye, Isabelle;
    • Van Damme, Nancy;
    • Stordeur, Sabine;
    • De Visschere, Pieter;
    • Taylor, Donatienne;
    • Wildiers, Hans;
    • Canon, Jean-Luc;
    • Carly, Birgit;
    • Cusumano, Pino G.;
    • de Azambuja, Evandro;
    • Desreux, Joëlle;
    • Duhoux, Francois P.;
    • van Dam, Peter;
    • Verhoeven, Didier;
    • Veldeman, Liv
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review.

    Published in:
    International Journal of Molecular Sciences, 2019, v. 20, n. 9, p. 2183, doi. 10.3390/ijms20092183
    By:
    • van Dam, Peter A.;
    • Verhoeven, Yannick;
    • Jacobs, Julie;
    • Wouters, An;
    • Tjalma, Wiebren;
    • Lardon, Filip;
    • Van den Wyngaert, Tim;
    • Dewulf, Jonatan;
    • Smits, Evelien;
    • Colpaert, Cécile;
    • Prenen, Hans;
    • Peeters, Marc;
    • Lammens, Martin;
    • Trinh, Xuan Bich
    Publication type:
    Article
    31
    32
    33
    34

    Fulvestrant (Faslodex™) in advanced breast cancer: clinical experience from a Belgian cooperative study.

    Published in:
    Breast Cancer Research & Treatment, 2008, v. 109, n. 1, p. 59, doi. 10.1007/s10549-007-9628-2
    By:
    • Patrick Neven;
    • Robert Paridaens;
    • Gino Pelgrims;
    • Marc Martens;
    • Alain Bols;
    • Jean Goeminne;
    • Anita Vindevoghel;
    • Jan Demol;
    • Barbara Stragier;
    • Jacques De Greve;
    • Christel Fontaine;
    • Danielle Van Den Weyngaert;
    • Dominique Becquart;
    • Marleen Borms;
    • Veronique Cocquyt;
    • Rudy Van Den Broecke;
    • Jean Selleslags;
    • Ahmad Awada;
    • Luc Dirix;
    • Peter Van Dam
    Publication type:
    Article
    35
    36
    37
    38
    39
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50